ETF Managers Group’s NeoGenomics NEO Stock Holding History

ETF Managers Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-156,558	Closed	-$2.03M	–	820
2022 Q1	$2.03M	Buy	+156,558	New	+$3.29M	0.04%	205

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

ETF Managers Group's NEO Position: Q2 2022 in Review

ETF Managers Group sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 156,558 shares — an estimated $2.03M sold.

ETF Managers Group first reported a position in NEO in Q1 2022 and held it in 1 quarter. The position peaked at $2.03M in Q1 2022. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

ETF Managers Group reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
ETF Managers Group sold 156,558 NeoGenomics shares in Q2 2022, an estimated $2.03M.
ETF Managers Group first reported a position in NeoGenomics in Q1 2022 and held it in 1 quarter.
ETF Managers Group's NeoGenomics position peaked at $2.03M in Q1 2022.
239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on ETF Managers Group's 13F filing for Q2 2022, filed 15 Aug 2022.